Clinical Trial Update: Insomnia and Drug Relapse Risk [Phase 3]

View source ↗

Summary

Phase 3 trial results update assessing the link between insomnia and relapse risk in patients with opioid use disorder. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Opioid Use Disorder

Snippet

Sponsor: Butler Hospital | Conditions: Poor Quality Sleep, Opiate Addiction | Phase 3 | Status: COMPLETED | Results posted: 2013-12-11